Why Moderna won’t share rights to the COVID-19 vaccine with the government that paid for its development – The Conversation US

A quiet monthslong legal fight between the U.S. National Institutes of Health and drugmaker Moderna over COVID-19 vaccine patents recently burst into public view. The outcome of the battle has important implications, not only for efforts to contain the…

Click here to view the original article.